Mr. Lee Jun Young, CEO of JS Link (South Korea), and Mr. Le Van Khoa, CEO of Gene Viet Molecular Biology Joint Stock Company (right) sign a contract for the construction of a Gene Testing Center
|
Per the agreement, JS Link will assume the role of consultant, providing advanced technology transfer and supplying the entire system of equipment for Gene Viet’s Gene Testing Center. Expected to be operational in Q2 2026, the center will become a facility for genetic decoding, AI application in risk assessment, and early detection of cancers and genetic disorders such as stroke and diabetes.
With a testing capacity of up to 500,000 samples per year, this will be the largest gene testing center in Asia and among the world’s leaders in DNA testing. It combines modern analysis technologies with AI and Big Data applications in human genetics, creating breakthroughs in personalized medicine based on individuals’ genetic maps for proactive disease prevention, treatment, stem cell research, and applications in healthcare and beauty.
“This collaboration with JS Link brings not only the most advanced technologies in genomics but also marks a pivotal turning point, positioning Vietnam as a shining star on the map of biotechnology research and application in the region and worldwide,” emphasized Mr. Le Van Khoa, CEO of Gene Viet Molecular Biology Joint Stock Company, during the event.
Mr. Lee Jun Young, CEO of JS Link (South Korea), and Mr. Le Van Khoa, CEO of Gene Viet Molecular Biology Joint Stock Company
|
This collaboration also materializes the orientation shift from cooperation inåŠ å·¥ to cooperation in technology transfer, research, and development in biotechnology, as emphasized during General Secretary To Lam’s state visit to South Korea from August 10 to 13, 2025.
About JS Link (South Korea)
Established in 2000, JS Link is a pioneer in biotechnology and genomics with over 20 years of experience. The company possesses comprehensive capabilities in genomics, proteomics, multi-omics, big biological data, and precision medicine. They have collaborated with numerous hospitals, government agencies, and global corporations.
JS Link is currently a strategic partner in several national gene projects in South Korea and leads initiatives in precision medicine based on genetic data. With a team of over 70 experts, including 10 PhD holders, JS Link asserts its position as a globally-scaled company in the industry.
About Gene Viet Molecular Biology Joint Stock Company
Gene Viet is a pioneer in Vietnam in DNA testing, whole human genome sequencing, genetic screening (PGS), cancer screening, and targeted therapy. The company owns an international-standard ISO 9001-certified testing laboratory, utilizing next-generation sequencing (NGS) technology from leading global brands such as Thermo Fisher and MGI.
With a testing accuracy of up to 99.9%, Gene Viet has successfully performed thousands of complex tests recognized internationally.
Gene Viet’s Main Services:
- DNA Relationship Testing
- Whole Human Genome Sequencing (Genomics)
- Cancer Screening and Targeted Therapy
- Pre-Implantation Genetic Screening (PGS)
Services
“Pacific Land Vietnam Revives Hanoi’s Hi-Tech Biotech Park After 17-Year Wait”
The capital city of Hanoi has finally commenced construction on Vietnam’s first and only hi-tech biotechnology park, spanning almost 200 hectares with a total investment of VND 7,400 billion. This groundbreaking project has overcome years of legal and planning hurdles, with Pacific Land Vietnam entrusted with over 5.6 thousand square meters to develop this ambitious initiative.
“Establishing Asia’s Premier Gene Testing Center”
On August 22, 2025, in Hanoi, JS Link Company (South Korea) and Gene Viet Molecular Biology Joint Stock Company officially signed a strategic cooperation agreement on the establishment, technology transfer, and provision of equipment for a modern, state-of-the-art gene testing center in the region.
“Livespo’s ESG 2025-2030: Forging a Sustainable Future”
With a strong commitment to sustainability, LiveSpo has embarked on an ambitious journey to integrate ESG (Environmental, Social, and Governance) factors into its business operations. This strategic initiative, spanning from 2025 to 2030, is a collaborative effort between LiveSpo, the Vietnam USAID IPSC (USAID Initiative for Private Sector Competitiveness) project, and FPT Digital.
The Rich Kid of Shark Tank: Self-Made Millionaire Pitches the Sharks, Leaving Shark Binh in Awe.
“Your family must be loaded! Who are your parents?” Shark Binh exclaimed, intrigued by the founder’s revelation of a staggering 100 billion VND personal investment, alongside two angel investors, in a startup. Yeast Era, a pioneer in its field, specializes in providing 100% protein products derived from microorganisms and is one of the first three factories in the world capable of producing this cutting-edge technology.
The High-Tech Biotech Park: A $1 Billion Project, Now a Vision or a Reality?
The Hanoi Hi-Tech Biotechnology Park in Bac Tu Liem District was once hailed as the “grand project of all projects”. This park was envisioned to be a hub for world-renowned biotechnology companies, a place where they could thrive and develop cutting-edge techniques. However, after 16 years, not a single phase has been implemented.
